GSK
Price
$37.56
Change
-$0.31 (-0.82%)
Updated
Apr 2, 03:58 PM (EDT)
Capitalization
88.13B
28 days until earnings call
JNJ
Price
$155.03
Change
+$1.79 (+1.17%)
Updated
Apr 2, 04:30 PM (EDT)
Capitalization
380.22B
13 days until earnings call
Ad is loading...

GSK vs JNJ

Header iconGSK vs JNJ Comparison
Open Charts GSK vs JNJBanner chart's image
GSK
Price$37.56
Change-$0.31 (-0.82%)
Volume$5.23K
Capitalization88.13B
Johnson & Johnson
Price$155.03
Change+$1.79 (+1.17%)
Volume$17.7K
Capitalization380.22B
GSK vs JNJ Comparison Chart
Loading...
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GSK vs. JNJ commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a Hold and JNJ is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (GSK: $37.87 vs. JNJ: $153.25)
Brand notoriety: GSK: Not notable vs. JNJ: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GSK: 100% vs. JNJ: 250%
Market capitalization -- GSK: $88.13B vs. JNJ: $380.22B
GSK [@Pharmaceuticals: Major] is valued at $88.13B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 2 FA rating(s) are green whileJNJ’s FA Score has 1 green FA rating(s).

  • GSK’s FA Score: 2 green, 3 red.
  • JNJ’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than GSK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 3 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).

  • GSK’s TA Score: 3 bullish, 5 bearish.
  • JNJ’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than GSK.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а -1.84% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.44%. For the same industry, the average monthly price growth was -1.53%, and the average quarterly price growth was -6.99%.

Reported Earning Dates

GSK is expected to report earnings on Apr 30, 2025.

JNJ is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.44% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than GSK($88.1B). JNJ has higher P/E ratio than GSK: JNJ (30.34) vs GSK (14.01). GSK YTD gains are higher at: 13.202 vs. JNJ (6.816). JNJ has higher annual earnings (EBITDA): 23.3B vs. GSK (9.08B). JNJ has more cash in the bank: 22.9B vs. GSK (4.99B). GSK has less debt than JNJ: GSK (18B) vs JNJ (29.3B). JNJ has higher revenues than GSK: JNJ (85.2B) vs GSK (30.3B).
GSKJNJGSK / JNJ
Capitalization88.1B380B23%
EBITDA9.08B23.3B39%
Gain YTD13.2026.816194%
P/E Ratio14.0130.3446%
Revenue30.3B85.2B36%
Total Cash4.99B22.9B22%
Total Debt18B29.3B61%
FUNDAMENTALS RATINGS
GSK vs JNJ: Fundamental Ratings
GSK
JNJ
OUTLOOK RATING
1..100
8419
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
7337
SMR RATING
1..100
4846
PRICE GROWTH RATING
1..100
4734
P/E GROWTH RATING
1..100
1052
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GSK's Valuation (8) in the Pharmaceuticals Major industry is in the same range as JNJ (20). This means that GSK’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for GSK (73). This means that JNJ’s stock grew somewhat faster than GSK’s over the last 12 months.

JNJ's SMR Rating (46) in the Pharmaceuticals Major industry is in the same range as GSK (48). This means that JNJ’s stock grew similarly to GSK’s over the last 12 months.

JNJ's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as GSK (47). This means that JNJ’s stock grew similarly to GSK’s over the last 12 months.

GSK's P/E Growth Rating (10) in the Pharmaceuticals Major industry is somewhat better than the same rating for JNJ (52). This means that GSK’s stock grew somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GSKJNJ
RSI
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
41%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
47%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 6 days ago
54%
Bullish Trend 3 days ago
41%
Declines
ODDS (%)
Bearish Trend 10 days ago
52%
Bearish Trend 9 days ago
42%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
45%
Aroon
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
37%
View a ticker or compare two or three
Ad is loading...
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRU111.690.01
+0.01%
Prudential Financial
GROY1.44N/A
N/A
Gold Royalty Corp
ORLA9.30-0.05
-0.53%
Orla Mining Ltd
LFUS193.09-3.65
-1.86%
Littelfuse
FGEN0.30-0.01
-3.16%
FibroGen

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
-2.25%
NVS - GSK
49%
Loosely correlated
-1.68%
PFE - GSK
47%
Loosely correlated
-3.16%
SNY - GSK
40%
Loosely correlated
-2.02%
JNJ - GSK
40%
Loosely correlated
-7.59%
AZN - GSK
38%
Loosely correlated
-1.22%
More

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-7.59%
PFE - JNJ
59%
Loosely correlated
-3.16%
BMY - JNJ
40%
Loosely correlated
-2.36%
ABBV - JNJ
40%
Loosely correlated
-1.55%
NVS - JNJ
40%
Loosely correlated
-1.68%
GSK - JNJ
40%
Loosely correlated
-2.25%
More